As primary intracranial tumors of the central nervous system (CNS), gliomas pose formidable
challenges in the field of oncology due to their aggressiveness, poor prognosis, high risk of …

Glioblastoma (GBM) remains the epitome of aggressiveness and lethality in the spectrum of
brain tumors, primarily due to the blood–brain barrier (BBB) that hinders effective treatment …

Magnetic hyperthermia has emerged as a highly promising technique for cancer therapy,
owing to its noninvasive nature, capacity to penetrate deep into tissues, and low influence …

Brain drug delivery is severely hindered by the presence of the blood–brain barrier (BBB). Its
functionality relies on the interactions of the brain endothelial cells with additional cellular …

This study investigated the use of magnetic fluid hyperthermia (MFH) for treating
glioblastoma multiforme (GBM), a deadly and treatment-resistant tumor. It considers the …

The concurrent use of hyperthermia and chemotherapy has attracted considerable interest
in the in situ treatment of cancer after surgical resection. In this study, poly (ε …

Glioblastoma (GBM) is the most aggressive and prevalent primary malignant tumor of the
central nervous system. Traditional chemotherapy has poor therapeutic effects and …

The application of lipid‐based nanoparticles for COVID‐19 vaccines and transthyretin‐
mediated amyloidosis treatment have highlighted their potential for translation to cancer …

Premature drug release in chemotherapy and hypoxic conditions in photodynamic therapy
(PDT) are perplexing problems in tumor treatment. Thus, it is of great significance to develop …

Gliomas are the most common primary tumors of the central nervous system, with
glioblastoma multiforme (GBM) having the highest incidence, and their therapeutic efficacy …